vs
Side-by-side financial comparison of NATIONAL RESEARCH CORP (NRC) and Plymouth Industrial REIT, Inc. (PLYM). Click either name above to swap in a different company.
Plymouth Industrial REIT, Inc. is the larger business by last-quarter revenue ($51.2M vs $35.2M, roughly 1.5× NATIONAL RESEARCH CORP). NATIONAL RESEARCH CORP runs the higher net margin — 5.1% vs -106.3%, a 111.4% gap on every dollar of revenue. On growth, Plymouth Industrial REIT, Inc. posted the faster year-over-year revenue change (-1.4% vs -4.6%). Over the past eight quarters, Plymouth Industrial REIT, Inc.'s revenue compounded faster (0.4% CAGR vs -0.2%).
National Research Corporation, doing business as NRC Health, is an American healthcare company which provides healthcare products and subscription-based solutions in United States and Canada. It was founded in 1981, and is based in Lincoln, Nebraska.
Plymouth Industrial REIT, Inc. is a real estate investment trust focused on owning, operating, and acquiring high-quality industrial properties including distribution centers, warehouses, and light industrial facilities across key U.S. logistics hubs. It serves tenants in e-commerce, retail, manufacturing, and third-party logistics sectors, supporting diverse business supply chain needs.
NRC vs PLYM — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2025
| Metric | ||
|---|---|---|
| Revenue | $35.2M | $51.2M |
| Net Profit | $1.8M | $-54.4M |
| Gross Margin | — | — |
| Operating Margin | 13.3% | -102.5% |
| Net Margin | 5.1% | -106.3% |
| Revenue YoY | -4.6% | -1.4% |
| Net Profit YoY | -72.6% | -248.5% |
| EPS (diluted) | $49.58 | $-1.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $35.2M | — | ||
| Q3 25 | $34.6M | $51.2M | ||
| Q2 25 | $34.0M | $47.2M | ||
| Q1 25 | $33.6M | $45.6M | ||
| Q4 24 | $36.9M | $47.6M | ||
| Q3 24 | $35.8M | $51.9M | ||
| Q2 24 | $35.0M | $48.7M | ||
| Q1 24 | $35.3M | $50.2M |
| Q4 25 | $1.8M | — | ||
| Q3 25 | $4.1M | $-54.4M | ||
| Q2 25 | $-106.0K | $-6.1M | ||
| Q1 25 | $5.8M | $5.8M | ||
| Q4 24 | $6.6M | $147.4M | ||
| Q3 24 | $5.7M | $-15.6M | ||
| Q2 24 | $6.2M | $1.3M | ||
| Q1 24 | $6.4M | $6.2M |
| Q4 25 | 13.3% | — | ||
| Q3 25 | 22.4% | -102.5% | ||
| Q2 25 | 4.7% | -10.3% | ||
| Q1 25 | 25.6% | — | ||
| Q4 24 | 26.0% | — | ||
| Q3 24 | 22.3% | -29.6% | ||
| Q2 24 | 25.3% | 2.7% | ||
| Q1 24 | 24.8% | — |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 11.9% | -106.3% | ||
| Q2 25 | -0.3% | -12.9% | ||
| Q1 25 | 17.2% | 12.8% | ||
| Q4 24 | 17.8% | 309.9% | ||
| Q3 24 | 15.9% | -30.1% | ||
| Q2 24 | 17.6% | 2.7% | ||
| Q1 24 | 18.0% | 12.4% |
| Q4 25 | $49.58 | — | ||
| Q3 25 | $0.18 | $-1.23 | ||
| Q2 25 | $-0.01 | $-0.14 | ||
| Q1 25 | $0.25 | $0.13 | ||
| Q4 24 | $0.27 | $3.24 | ||
| Q3 24 | $0.24 | $-0.35 | ||
| Q2 24 | $0.26 | $0.03 | ||
| Q1 24 | $0.27 | $0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.1M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $14.0M | $470.1M |
| Total Assets | $134.9M | $1.6B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $4.1M | — | ||
| Q3 25 | $2.2M | — | ||
| Q2 25 | $5.3M | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $4.2M | — | ||
| Q3 24 | $3.5M | — | ||
| Q2 24 | $485.0K | — | ||
| Q1 24 | $1.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $646.4M | ||
| Q3 24 | $48.7M | — | ||
| Q2 24 | $33.3M | — | ||
| Q1 24 | $35.2M | — |
| Q4 25 | $14.0M | — | ||
| Q3 25 | $14.3M | $470.1M | ||
| Q2 25 | $21.3M | $539.6M | ||
| Q1 25 | $29.7M | $571.0M | ||
| Q4 24 | $31.3M | $579.5M | ||
| Q3 24 | $34.6M | $436.5M | ||
| Q2 24 | $40.2M | $475.2M | ||
| Q1 24 | $36.9M | $484.6M |
| Q4 25 | $134.9M | — | ||
| Q3 25 | $135.7M | $1.6B | ||
| Q2 25 | $141.4M | $1.6B | ||
| Q1 25 | $135.2M | $1.4B | ||
| Q4 24 | $132.5M | $1.4B | ||
| Q3 24 | $131.8M | $1.5B | ||
| Q2 24 | $119.1M | $1.4B | ||
| Q1 24 | $120.9M | $1.4B |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 1.12× | ||
| Q3 24 | 1.41× | — | ||
| Q2 24 | 0.83× | — | ||
| Q1 24 | 0.95× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $7.2M | $20.0M |
| Free Cash FlowOCF − Capex | $6.1M | — |
| FCF MarginFCF / Revenue | 17.2% | — |
| Capex IntensityCapex / Revenue | 3.2% | — |
| Cash ConversionOCF / Net Profit | 3.99× | — |
| TTM Free Cash FlowTrailing 4 quarters | $15.7M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $7.2M | — | ||
| Q3 25 | $13.8M | $20.0M | ||
| Q2 25 | $-1.1M | $23.4M | ||
| Q1 25 | $6.6M | $15.6M | ||
| Q4 24 | $6.4M | $96.1M | ||
| Q3 24 | $9.4M | $17.6M | ||
| Q2 24 | $6.8M | $19.9M | ||
| Q1 24 | $12.0M | $16.6M |
| Q4 25 | $6.1M | — | ||
| Q3 25 | $10.2M | — | ||
| Q2 25 | $-4.1M | — | ||
| Q1 25 | $3.7M | — | ||
| Q4 24 | $1.9M | — | ||
| Q3 24 | $7.8M | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $7.9M | — |
| Q4 25 | 17.2% | — | ||
| Q3 25 | 29.4% | — | ||
| Q2 25 | -12.2% | — | ||
| Q1 25 | 10.9% | — | ||
| Q4 24 | 5.2% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | 4.3% | — | ||
| Q1 24 | 22.4% | — |
| Q4 25 | 3.2% | — | ||
| Q3 25 | 10.4% | — | ||
| Q2 25 | 8.8% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 12.0% | — | ||
| Q3 24 | 4.5% | — | ||
| Q2 24 | 15.0% | — | ||
| Q1 24 | 11.7% | — |
| Q4 25 | 3.99× | — | ||
| Q3 25 | 3.34× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 1.15× | 2.67× | ||
| Q4 24 | 0.97× | 0.65× | ||
| Q3 24 | 1.66× | — | ||
| Q2 24 | 1.10× | 15.12× | ||
| Q1 24 | 1.89× | 2.67× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.